Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Cardlytics To Contact Him Directly To Discuss Their Options

If you suffered losses exceeding $50,000 in Cardlytics between March 14, 2024 and August 7, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310)

NEW YORK , Feb. 7, 2025 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX) and reminds investors of the March 25, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Investors who suffered losses exceeding $50,000 in Cardlytics between March 14, 2024 and August 7, 2024 are encouraged to contact Faruqi & Faruqi partner James (Josh) Wilson for a consultation. It is important for investors to understand their legal rights and options in such cases, and seeking the advice of a securities litigation partner can provide valuable insights.

Cardlytics, Inc. has been facing a federal securities class action, and investors who believe they may have a claim against the Company should act promptly to protect their interests. The deadline to seek the role of lead plaintiff in the class action is March 25, 2025, and investors should not delay in seeking legal counsel.

Contact Faruqi & Faruqi Partner Josh Wilson for more information and to discuss your options:

Phone: 877-247-4292 or 212-983-9330 (Ext. 1310)

Investing in securities carries inherent risks, and it is important for investors to be aware of their rights and options in case of losses. Seeking the advice of a securities litigation partner can help investors navigate complex legal processes and make informed decisions.

For more information about the investigation into potential claims against Cardlytics, Inc., investors can contact Faruqi & Faruqi partner Josh Wilson directly. It is crucial for investors to take proactive steps to protect their legal rights and interests in such cases.

Impact on Individuals

Investors who suffered losses exceeding $50,000 in Cardlytics between March 14, 2024 and August 7, 2024 may be eligible to seek legal redress through the federal securities class action filed against the Company. Seeking the advice of a securities litigation partner can help affected individuals understand their options and potentially recover their losses.

Impact on the World

The investigation into potential claims against Cardlytics, Inc. by Faruqi & Faruqi, LLP reflects the importance of holding companies accountable for any alleged misconduct or securities violations. Securities litigation plays a crucial role in upholding investor rights and maintaining transparency in the financial markets.

Conclusion

If you are an investor who suffered losses exceeding $50,000 in Cardlytics between March 14, 2024 and August 7, 2024, it is essential to seek legal guidance promptly. Contacting Faruqi & Faruqi partner Josh Wilson can help you understand your rights and options in the federal securities class action against the Company. Act now to protect your interests and explore potential avenues for recovery.